Miwako Kobayashi - Concepedia

Author

Miwako Kobayashi

Centers for Disease Control and Prevention

Also Known As

Chukwuma Mbaeyi, M. Kobayashi, MIWAKO KOBAYASHI, Miwako Kobayashi, Rachel Klos

126

Publications

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Emory University Epidemic Intelligence Service University of Colorado Denver

About

Miwako Kobayashi is an author at Centers for Disease Control and Prevention specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.6K
2	Public Health	13	14	1.5K
3	Epidemiology	13	14	1.5K
4	Global Health	3	3	85
5	Immunology	3	3	424

Miwako Kobayashi

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity Mark W. Tenforde, Wesley H. Self, Katherine Adams, JAMA	2021	671
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study Adam S. Lauring, Mark W. Tenforde, James D. Chappell, BMJ	2022	666
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 Wesley H. Self, Mark W. Tenforde, Jillian P. Rhoads, MMWR Morbidity and Mortality Weekly Report	2021	445
Public Health Responses to COVID-19 Outbreaks on Cruise Ships — Worldwide, February–March 2020 Leah F. Moriarty, Mateusz M. Pluciński, Barbara J. Marston, MMWR Morbidity and Mortality Weekly Report Virus EpidemiologyCovid-19 OutbreaksDisease OutbreakCovid-19 EpidemiologyFebruary–march 2020	2020	426
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Miwako Kobayashi, Jennifer L. Farrar, Ryan Gierke, MMWR Morbidity and Mortality Weekly Report	2022	326
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices Almea Matanock, Grace Lee, Ryan Gierke, MMWR Morbidity and Mortality Weekly Report	2019	324
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 Mark W. Tenforde, Samantha M. Olson, Wesley H. Self, MMWR Morbidity and Mortality Weekly Report	2021	319
Surveillance of Vaccination Coverage Among Adult Populations —United States, 2018 Peng-Jun Lu, Mei-Chuan Hung, Anup Srivastav, MMWR Surveillance Summaries	2021	313
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021 Mark W. Tenforde, Wesley H. Self, Eric A. Naioti, MMWR Morbidity and Mortality Weekly Report ImmunodeficienciesMrna VaccinesCovid-19 EpidemiologyVaccine HesitancySustained Effectiveness	2021	246
Compendium of Measures to Control<i>Chlamydia psittaci</i>Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017 Gary Balsamo, Angela M. Maxted, Joanne Midla, Journal of Avian Medicine and Surgery Parasitic DiseasePathologyNasal DischargesInfection ControlPublic Health	2017	245

Page 1